FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions
horizonal rule
Dockets Management

Up | AC Home Page

Food and Drug Administration

Blood Products Advisory Committee

April 26, 2007

SLIDES

Introduction and Issues Related to Implementation of Blood Donor Screening for Antibodies to T. cruzi Infection, Robert Duncan, Ph.D., DETTD, OBRR, FDA (pdf)

Introduction of Issues Related to the Potential Transmission of T. cruzi by Human Cells, Tissues and Cellular and Tissue-Based Products, Melissa A. Greenwald, M.D., CDR, USPHS, DHT, OCTGT, FDA (pdf)

Ortho T. cruzi ELISA Test System Experience, Susan Stramer, Ph.D., American Red Cross (pdf)

Public Health Impact of Donor Screening for T. cruzi Infection, Susan P. Montgomery, D.V.M., M.P.H., Centers for Disease Control and Prevention (pdf)

Potential Strategies for Targeted Testing for T. cruzi Infection in Repeat Donors, Michael P. Busch, M.D., Ph.D., Brian Custer, Ph.D., M.P.H., Blood Systems Research Institute (pdf)

Open Public Hearing

Abbott’s PRISM Chagas Assay, Ben Marchlewicz, Ph.D., PRISM R&D, Program Manager (pdf)

Processed “Conventional” HCT/Ps and Low Risk for Chagas’ Disease, Scott Brubaker, CTBS, Chief Policy Officer (pdf)

Up | AC Home Page

Page last updated May 25, 2007 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management